The 6^th Workshop on Microbial Resources

“Novel approaches in natural product-based drug discovery - technological and strategic aspects”

We are pleased to announce you of the second circular for 6^th Workshop on Microbial Resources. Passion to natural product-based drug discovery tends to be different from continents to continents, from company to company, and from individual scientists to scientists. So far the workshops held during the past two years were all very informative and fruitful because of the well-considered plans from international viewpoints. See the following website:

http://www.tamagawa.ac.jp/sisetu/gakujutu/alsrc/wmre.htm

The 3^rd Workshop in Hakone last June revealed that an over-the-beer discussion till late in the evening makes people new friendship and solves our problems. We are thus planning the 6^th Workshop on the foot of Mt. Fuji. You are kindly asked to make a formal registration by the end of September. Why don’t you come over to Japan prior to attend BMP2002 held in Honolulu, Hawaii following this workshop.

Date:	October 25 ,Friday – 26, Saturday
Place:	Hotel Evergreen Fuji 4658-1 Kamiyoshida, Fujiyoshida, Yamanashi Prefecture 403-0005, Japan TEL +81 555 24 5131 FAX +81 555 24 5711
	On the foot of Mt. Fuji, 5 km from Fujiyoshida station, 6 km from Lake Kawaguchi
Organizer	Toru Okuda & Toshikazu Oki, Applied Life Science Research Center, Tamagawa University Research Institute
First Circular	Pre-registration
Second Circular	Registration should be made via email, fax or letter by the end of September
Final circular	Early October to the registered participants
Admission fee:	15,000 yen including hotel charge, two meals, and late evening discussion fee The fee is expected to be paid at the registration desk

Program (some of the titles are tentative):

Topics “Novel approaches in natural product-based drug discovery - technological and strategic issues”

October 25, Friday
15:00	On-site registration, check-in, and orientation
Program 1		Seminar Room
15:45	Opening	Toshikazu Oki, Tamagawa University Research Institute
16:00	Natural Product-based Drug Discovery Today	Malcolm Page, Basilea Pharmaceutica LTd, Switzerland
16:45	Microbial isolation: first important step of the natural product study	Yasuhisa Tsurumi, Fujisawa Pharmaceutical Co.
17:30	Free time
18:00	Dinner	Restaurant
Program 2		Party Room
20:00	Free discussion over the beer, wine, sake or whatever	all participants
24:00	Go to bed as you like
October 26, Saturday
07:30	Breakfast	Restaurant
08:30	Check-out
Program 3		Seminar Room
09:00	Fungal taxonomy to increase the probability of success of HTS	Marc Stadler, Bayer AG, Germany
09:45	To construct an attractive pure compound NP-library	Lutz Mueller-Kuhrt, AnalytiCon Discovery GmbH, Germany
10:30	Closing	Toru Okuda, Tamagawa University Research Institute
10:45
11:00	Leaving the hotel
Program 4	Outdoor activity (optional)
	Sightseeing around Fuji Five Lakes
	Collecting mushrooms or other isolation sources
	Taking a bath in outside hot-spa (Onsen)

Participants are expected from:

Government, National Institutions, and Academia

Japan Bioindustry Association, Nishihara Environmental Sanitation Research Corp., Meijo University, Biological Resource Center (N-BRC), Institute of Scientific and Industrial Research (ISIR), RIKEN, University of Tokyo, Tamagawa University, Tohoku University, Toyama Prefectural University

Private sector (Japan)

Ajinomoto Corp., Nissan Chemical Industries, HyphaLink Laboratories, Kyowa Hakko Co., Nimura Genetic Solutions Inc., Fujitsu Social Science Laboratory Ltd., Nippon Roche Research Center, Oji Paper Co., Meiji Seika Kaisha, Tanabe Seiyaku Co., Takada Chemical Industries, Akita Konno Co., Kubota Engineer Office, Asahi Kasei Corporation, Chugai Pharmaceutical Co., Fuji Photo Film Co., House Food Co., TOTO Ltd., Yamamouchi Pharmaceutical Co., Sankyo Co., Mitsubishi Pharma Corp., Fujisawa Pharmaceutical Co., Godo Shusei Co., Nimura Genetic Solutions Inc., HyphaLink Laboratories, Tanabe Seiyaku Co. Discovery Research Laboratory, Yokohama Bank Research Institute, Taiho Pharmaceutical Co., Hitachi Government & Public Corporation System Engineering, Sankyo Chemical Co., Nissan Chemical Co., Nippon Shinyaku Co., Shikiieda Chemicals Co.,

Private sector (World-wide)

AnalytiCon Discovery GmbH., Bayer AG., Basilea Pharmaceutica Ltd., MerLion Pharmaceutical Pte Ltd., MycoSynthetix, Inc., Cerylid Biosciences, Relica Pharmaceuticals, Sugen Inc.

[to the previous page]